Evidence map›Paper›PMID 34604232›Full record

ArticleFrontiers in cell and developmental biology2021

Metabolites Profiling of Melanoma Interstitial Fluids Reveals Uridine Diphosphate as Potent Immune Modulator Capable of Limiting Tumor Growth.

Eleonora Vecchio, Carmen Caiazza, Selena Mimmi, Angelica Avagliano, Enrico Iaccino, Teresa Brusco, Nancy Nisticò, Domenico Maisano, Annamaria Aloisio, Ileana Quinto and 15 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 2 institutions in 1 country.

Eleonora VecchioDepartment of Experimental and Clinical Medicine, University of Catanzaro "Magna Graecia", Catanzaro, Italy.
Carmen CaiazzaDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Selena MimmiDepartment of Experimental and Clinical Medicine, University of Catanzaro "Magna Graecia", Catanzaro, Italy.
Angelica AvaglianoDepartment of Public Health, University of Naples Federico II, Naples, Italy.
Enrico IaccinoDepartment of Experimental and Clinical Medicine, University of Catanzaro "Magna Graecia", Catanzaro, Italy.
Teresa BruscoDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Nancy NisticòDepartment of Experimental and Clinical Medicine, University of Catanzaro "Magna Graecia", Catanzaro, Italy.
Domenico MaisanoDepartment of Experimental and Clinical Medicine, University of Catanzaro "Magna Graecia", Catanzaro, Italy.
Annamaria AloisioDepartment of Experimental and Clinical Medicine, University of Catanzaro "Magna Graecia", Catanzaro, Italy.
Ileana QuintoDepartment of Experimental and Clinical Medicine, University of Catanzaro "Magna Graecia", Catanzaro, Italy.
Maurizio RennaDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Giuseppina DivisatoDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Simona RomanoDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Martina TufanoDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Massimo D'AgostinoDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Elena VigliarDepartment of Public Health, University of Naples Federico II, Naples, Italy.
Antonino IaccarinoDepartment of Public Health, University of Naples Federico II, Naples, Italy.
Chiara MignognaDepartment of Health Sciences, Magna Graecia University, Catanzaro, Italy.
Francesco AndreozziDepartment of Medical and Surgical Sciences, University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
Gaia Chiara ManninoDepartment of Medical and Surgical Sciences, University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
Rosangela SpigaDepartment of Medical and Surgical Sciences, University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
Mariano StornaiuoloDepartment of Pharmacy, University of Napoli Federico II, Naples, Italy.
Alessandro ArcucciDepartment of Public Health, University of Naples Federico II, Naples, Italy.
Massimo MallardoDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Giuseppe FiumeDepartment of Experimental and Clinical Medicine, University of Catanzaro "Magna Graecia", Catanzaro, Italy.
University of Naples Federico II · ITMagna Graecia University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor interstitial fluid (TIF) surrounds and perfuses tumors and collects ions, metabolites, proteins, and extracellular vesicles secreted by tumor and stromal cells. Specific metabolites, accumulated within the TIF, could induce metabolic alterations of immune cells and shape the tumor microenvironment. We deployed a metabolomic approach to analyze the composition of melanoma TIF and compared it to the plasma of C57BL6 mice, engrafted or not with B16-melanoma cells. Among the classes of metabolites analyzed, monophosphate and diphosphate nucleotides resulted enriched in TIF compared to plasma samples. The analysis of the effects exerted by guanosine diphosphate (GDP) and uridine diphosphate (UDP) on immune response revealed that GDP and UDP increased the percentage of CD4

Indexed as

anti-tumor immunityB16 engraftmentmetabolite profilingTIL (tumor infiltrating lymphocytes)UDP

Identifiers

PMID34604232
PMCPMC8486041
OpenAlexW3199502312

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.